Tag: opioid use disorder market share

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Opioid Use Disorder (OUD) Market Over The Five-Year Period 2025–2029?

The market size for opioid use disorder (oud) has expanded quickly over recent years. It is anticipated to expand from $3.96 billion in 2024 to $4.37 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.5%. The historical growth of this market can be linked to several factors, including heightened prescription rates, prevailing pain management practices, pharmaceutical marketing efforts, and the societal stigmatization associated with addiction.

The market for opioid use disorder (OUD) is projected to experience substantial growth in the upcoming years. It is anticipated to reach “$6.91 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.1%. This expansion during the forecast period is primarily driven by factors such as regulatory actions, an increased emphasis on alternative methods for pain management, broadened access to treatment, and various public health programs. Key trends expected over the forecast horizon encompass technological advancements in therapeutic solutions, personalized approaches to treatment, models of integrated care, support programs within communities, and strategies for early intervention and prevention.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Opioid Use Disorder (OUD) Industry?

The increasing number of opioid addiction cases is projected to stimulate the expansion of the opioid use disorder (OUD) market moving forward. Opioid addiction is characterized as a medical condition involving the compulsive and prolonged use of opioids, which has damaging effects on the body. Opioids are known to induce feelings of euphoria and pain relief, but their continuous consumption can lead to the development of tolerance, requiring higher doses to achieve the same effect, potentially resulting in opioid use disorder. For example, in March 2024, according to the Centers for Disease Control and Prevention, a US-based public health agency, the rate of synthetic opioid drug overdosage increased by 4.1%, rising from 21.8 to 22.7 between 2021 and 2022. Therefore, the growing incidence of opioid addiction cases is a significant factor driving the growth of the opioid use disorder (OUD) market.

How Is The Opioid Use Disorder (OUD) Market Segmented?

The opioid use disorder (oud)market covered in this report is segmented –

1) By Drug Type: Buprenorphine; Naltrexone; Methadone

2) By Route of Administration: Oral; Parenteral

3) By Age Group: 19 To 40; 41 To 60; 61 And Over

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies And Stores; Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone; Buprenorphine Tablets; Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets; Vivitrol

3) By Methadone: Methadone Tablets; Methadone Oral Solution

What Trends Are Expected To Drive The Opioid Use Disorder (OUD) Market?

A prominent and growing trend within the Opioid Use Disorder (OUD) market is product innovation. Major companies engaged in the Opioid Use Disorder (OUD) market are introducing innovative products to uphold their market presence. For example, in May 2023, the U.S. Food and Drug Administration, a federal agency based in the US, authorized Brixadi (buprenorphine) extended-release injection for addressing moderate to severe Opioid Use Disorder (OUD). Brixadi comes in two distinct dosage forms: a weekly injection for patients who started treatment with a single dose of a transmucosal buprenorphine product or are currently using the medication, and a monthly version for those already on the medication.

Which Leading Companies Dominate The Opioid Use Disorder (OUD) Market Share?

Major companies operating in the opioid use disorder (OUD) market include Pfizer Inc., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Opioid Use Disorder (OUD) Market?

North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Opioid Use Disorder (OUD) Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

Browse Through More Reports Similar to the Global Opioid Use Disorder (OUD) Market 2025, By The Business Research Company

Used Truck Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/used-truck-global-market-report

Used Cars Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/used-cars-global-market-report

Non Opioid Pain Patch Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-opioid-pain-patch-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Opioid Use Disorder (OUD) Market Size From 2025 to 2034?

The market size for opioid use disorder (oud) has experienced significant growth in recent years. It is projected to increase from $3.96 billion in 2024 to $4.37 billion in 2025, at a compound annual growth rate (CAGR) of 10.5%. Factors such as higher prescription rates, pain management protocols, drug promotion, and the stigma associated with addiction have contributed to the growth in the historical period.

The market for opioid use disorder (oud) is predicted to experience substantial expansion in the impending years, and it is projected to reach$6.91 billion by 2029 with a compound annual growth rate (CAGR) of 12.1%. This anticipated growth within the forecast period can be credited to regulatory actions, emphasis on alternative pain management solutions, extension of treatment accessibility, and public health initiatives. Foreseeable trends within the forecast period include advancements in treatment technology, personalized treatment strategies, combined care frameworks, community-oriented support schemes, as well as early detection and prevention.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Opioid Use Disorder (OUD) Market?

The surge in opioid addiction incidents is anticipated to drive the expansion of the opioid use disorder (OUD) market in the future. Opioid addiction is a medical issue defined by obsessive and constant opioid intake which poses detrimental impacts on the body. The continued utilization of opioids, which can generate sensations of euphoria and alleviate pain, can result in the buildup of tolerance. This requires larger doses to elicit the same response, potentially leading to opioid use disorder. For instance, the Centers for Disease Control and Prevention, a public health agency based in the US, reported in March 2024 that the synthetic opioid overdose rate had escalated by 4.1%, rising from 21.8 to 22.7 between 2021 and 2022. Thus, the escalating count of opioid addiction instances stimulates the expansion of the opioid use disorder (OUD) market.

Which Key Market Segments Comprise the Opioid Use Disorder (OUD) Market and Drive Its Revenue Growth?

The opioid use disorder (oud)market covered in this report is segmented –

1) By Drug Type: Buprenorphine; Naltrexone; Methadone

2) By Route of Administration: Oral; Parenteral

3) By Age Group: 19 To 40; 41 To 60; 61 And Over

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies And Stores; Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone; Buprenorphine Tablets; Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets; Vivitrol

3) By Methadone: Methadone Tablets; Methadone Oral Solution

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

Which Areas Are Leading Regions in the Opioid Use Disorder (OUD) Market Expansion Across the Globe?

North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Strategic Trends Steering theOpioid Use Disorder (OUD) Market Direction?

A prominent trend gaining traction within the opioid use disorder (OUD) market is product innovation. To maintain their market standings, top businesses functioning within the OUD sector are focusing on developing novel products. For example, in May 2023, Brixadi (buprenorphine), an extended-release injection for treating moderate to severe OUD, gained approval from the U.S. Food and Drug Administration, a federal agency based in the U.S. Brixadi comes in two dosage forms: a weekly injection for patients who have commenced treatment with a single dose of a transmucosal buprenorphine product or are already on the medication, and a monthly version for those presently under the medication.

View the full report here:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

How Is the Opioid Use Disorder (OUD) Market Conceptually Defined?

Opioid use disorder (OUD) is a chronic brain disease resulting from prolonged use of opioids, including both prescription painkillers and illegal opioids. Opioid use disorder can develop due to genetic, environmental, and behavioral factors.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12586

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Opioid Use Disorder (OUD) Market Growth in 2025?

In the recent past, there has been a notable acceleration in the market size of opioid use disorder (OUD). It is projected that the market, which is valued at $3.96 billion in 2024, will escalate to $4.39 billion in 2025, registering a compound annual growth rate (CAGR) of 10.9%. The growth observed in the earlier period can be traced back to factors such as high prescription rates, effective pain management techniques, strategic drug marketing, and the stigma associated with addiction.

What Is the Forecast for the Opioid Use Disorder (OUD) Market Size Through 2029?

Expectations are high for the opioid use disorder (OUD) market to experience significant expansion in the forthcoming years, with projections suggesting a growth to $6.94 billion by 2029, registering a compound annual growth rate (CAGR) of 12.1%. The anticipated growth within the forecast period can be linked to factors like regulatory measures, emphasis on alternative pain management strategies, widened scope of treatment access, and public health campaigns. Key trends emerging in the forecast period encompass advancements in treatment technology, personalized treatment techniques, the adoption of integrated care models, the establishment of community-based support schemes, and a higher degree of early intervention and prevention.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

What are the Key Market Players in Opioid Use Disorder (OUD) Market and How They’re Evolving?

Major companies operating in the opioid use disorder (OUD) market include Pfizer Inc., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc.

What Are the Primary Growth Drivers in the Opioid Use Disorder (OUD) Market?

The escalating cases of opioid addiction are anticipated to fuel the expansion of the opioid use disorder (OUD) market. A medical condition marked by obsessive and consistent use of opioids leading to harmful effects defines opioid addiction. These substances have the capability to generate feelings of euphoria and relieve pain, but their sustained use can lead to tolerance, necessitating larger doses to achieve the desired result, potentially resulting in opioid use disorder. For example, the Centers for Disease Control and Prevention, a health agency based in the United States, noted a surge of 4.1% in synthetic opioid drug overdosage rates in March 2024, growing from a rate of 21.8 to 22.7 between 2021 and 2022. Hence, the rising opioid addiction cases serve as a significant factor propelling the OUD market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

What Are the Leading Segments in the Global Opioid Use Disorder (OUD) Industry?

The opioid use disorder (OUD) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

What Are the Key Market Trends in the Opioid Use Disorder (OUD) Industry?

A significant trend in the opioid use disorder (OUD) market is product innovation. In order to maintain their industry standing, leading companies are introducing novel products. For instance, in May 2023, Brixadi (buprenorphine) extended-release injection was given the green light by the U.S. Food and Drug Administration, a federal agency based in the U.S., for the treatment of moderate to severe opioid use disorder (OUD). Brixadi comes in two dosage variations: a weekly injection for patients who began treatment with a single dose of a transmucosal buprenorphine product or those still on the medication, and a monthly option for those who are already under medication.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

What Is the Regional Outlook for the Opioid Use Disorder (OUD) Market?

North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12586

This Report Delivers Insight On:

1. How big is the opioid use disorder (oud) market, and how is it changing globally?

2. Who are the major companies in the opioid use disorder (oud) market, and how are they performing?

3. What are the key opportunities and risks in the opioid use disorder (oud) market right now?

4. Which products or customer segments are growing the most in the opioid use disorder (oud) market?

5. What factors are helping or slowing down the growth of the opioid use disorder (oud) market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the opioid use disorder (oud) industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Opioid Use Disorder (OUD) Market Size Shifted, And What Is the Outlook Through 2034?

In the recent past, there has been a notable acceleration in the market size of opioid use disorder (OUD). It is projected that the market, which is valued at $3.96 billion in 2024, will escalate to $4.39 billion in 2025, registering a compound annual growth rate (CAGR) of 10.9%. The growth observed in the earlier period can be traced back to factors such as high prescription rates, effective pain management techniques, strategic drug marketing, and the stigma associated with addiction.

Expectations are high for the opioid use disorder (OUD) market to experience significant expansion in the forthcoming years, with projections suggesting a growth to $6.94 billion by 2029, registering a compound annual growth rate (CAGR) of 12.1%. The anticipated growth within the forecast period can be linked to factors like regulatory measures, emphasis on alternative pain management strategies, widened scope of treatment access, and public health campaigns. Key trends emerging in the forecast period encompass advancements in treatment technology, personalized treatment techniques, the adoption of integrated care models, the establishment of community-based support schemes, and a higher degree of early intervention and prevention.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

Which Factors and External Forces Are Driving Demand in the Opioid Use Disorder (OUD) Market?

The escalating cases of opioid addiction are anticipated to fuel the expansion of the opioid use disorder (OUD) market. A medical condition marked by obsessive and consistent use of opioids leading to harmful effects defines opioid addiction. These substances have the capability to generate feelings of euphoria and relieve pain, but their sustained use can lead to tolerance, necessitating larger doses to achieve the desired result, potentially resulting in opioid use disorder. For example, the Centers for Disease Control and Prevention, a health agency based in the United States, noted a surge of 4.1% in synthetic opioid drug overdosage rates in March 2024, growing from a rate of 21.8 to 22.7 between 2021 and 2022. Hence, the rising opioid addiction cases serve as a significant factor propelling the OUD market’s growth.

Which Segments in the Opioid Use Disorder (OUD) Offer the Most Growth?

The opioid use disorder (OUD) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Opioid Use Disorder (OUD) Market?# Market?

North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Cutting-Edge Market Trends Are Expected to Drive theOpioid Use Disorder (OUD) Market’s Growth?

A significant trend in the opioid use disorder (OUD) market is product innovation. In order to maintain their industry standing, leading companies are introducing novel products. For instance, in May 2023, Brixadi (buprenorphine) extended-release injection was given the green light by the U.S. Food and Drug Administration, a federal agency based in the U.S., for the treatment of moderate to severe opioid use disorder (OUD). Brixadi comes in two dosage variations: a weekly injection for patients who began treatment with a single dose of a transmucosal buprenorphine product or those still on the medication, and a monthly option for those who are already under medication.

View the full report here:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

What Are the Key Elements That Define the Opioid Use Disorder (OUD) Market?

Opioid use disorder (OUD) is a chronic brain disease resulting from prolonged use of opioids, including both prescription painkillers and illegal opioids. Opioid use disorder can develop due to genetic, environmental, and behavioral factors.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12586

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theOpioid Use Disorder (OUD) Market?

The rising incidence of opioid dependency is projected to fuel the expansion of the opioid use disorder (OUD) market in the future. Opioid dependency is defined as a medical state that involves continuous and obsessive usage of opioids, which has detrimental effects on the human body. The administration of opioids can provide a feeling of elation and analgesia, and their prolonged consumption could result in an increased tolerance. Consequently, larger doses are required to sustain the same impact, potentially leading to opioid use disorder. For example, in March 2024, the Centers for Disease Control and Prevention, a health organization based in the United States, reported a 4.1% increase in synthetic opioid drug overdoses, from 21.8 to 22.7 between 2021 and 2022. Hence, the escalating number of opioid dependency instances is a key driver for the opioid use disorder (OUD) market’s growth.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

#What Long-Term Growth Rate is Expected for theOpioid Use Disorder (OUD) Market Between 2025 and 2034?

The market size of the opioid use disorder (OUD) has experienced rapid expansion in recent years. It is projected to escalate from $3.96 billion in 2024 to $4.39 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.9%. The significant growth observed in the historic period can be traced back to factors such as higher prescription rates, pain management procedures, drug promotion, and the stigma associated with addiction.

The market size for opioid use disorder (OUD) is anticipated to witness significant growth in the coming years, reaching $6.94 billion in 2029 with a compound annual growth rate (CAGR) of 12.1%. This anticipated rise in the forecast period is ascribed to elements such as regulatory interventions, emphasis on alternate pain management strategies, extended access to treatments, and initiatives in public health. Key trends expected to emerge through the forecast period include advancements in treatment technology, personalized treatment methods, incorporation of care models, support programs rooted in community, and emphasis on initial intervention and prevention.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12586

Which Cutting-Edge Market Trends Are Expected to Drive theOpioid Use Disorder (OUD) Market’s Growth?

Innovative product creation is emerging as a significant trend in the opioid use disorder (OUD) market. Leading corporations in the OUD market are introducing fresh and innovative products to maintain their competitive edge. For example, in May 2023, Brixadi (buprenorphine) extended-release injection was given the green light by the U.S. Food and Drug Administration, a federal agency based in the United States, for the treatment of moderate to severe opioid use disorder (OUD). Brixadi is offered in two dosage types: a weekly injection for patients who initiated treatment with a single dosage of a transmucosal buprenorphine product or those who are already on medication, and a monthly version for those who are consistently receiving the medication.

What Are the Leading Market Players Impacting theOpioid Use Disorder (OUD) Market’s Growth Trend?

Major companies operating in the opioid use disorder (OUD) market include Pfizer Inc., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

How Are the Key Segments of the Opioid Use Disorder (OUD) Market Driving Opportunities and Innovations?

The opioid use disorder (OUD) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theOpioid Use Disorder (OUD) Market?# Market Expansion?

North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Opioid Use Disorder (OUD) Maret 2025, By The Business Research Company:

Oral Thin Films Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report

Used Cars Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/used-cars-global-market-report

Used Truck Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/used-truck-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Are the Projected Expansion Rates of the Opioid Use Disorder (OUD) Market for the Next Decade?

The opioid use disorder (OUD) market has expanded rapidly in recent years. It is projected to grow from $3.96 billion in 2024 to $4.39 billion in 2025, with a CAGR of 10.9%. The factors that have contributed to its historical growth include increased prescription rates, evolving pain management practices, aggressive drug marketing, and the stigma surrounding addiction.

The opioid use disorder (OUD) market is projected to expand rapidly, reaching $6.94 billion by 2029 with a CAGR of 12.1%. Growth will be driven by regulatory interventions, increased emphasis on alternative pain management strategies, improved treatment accessibility, and the implementation of public health initiatives. Emerging trends will include advancements in treatment technologies, personalized therapy approaches, integrated care models, the rise of community-based support programs, and an emphasis on early intervention and prevention strategies.

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the opioid use disorder (oud) Market?

The increasing number of opioid addiction cases is expected to drive the growth of the opioid use disorder (OUD) market. Opioid addiction results in harmful health effects and can lead to opioid use disorder. The Centers for Disease Control and Prevention reported in March 2024 a rise in synthetic opioid overdoses. This growing addiction crisis is propelling the OUD market.

Request Your Free Opioid Use Disorder (OUD) Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

Which Companies Are Redefining the Future of the Opioid Use Disorder (OUD) Market?

Major companies operating in the opioid use disorder (OUD) market include:

• Pfizer Inc._x000D_

• Novartis AG_x000D_

• Viatris Inc._x000D_

• Teva Pharmaceutical Industries Ltd._x000D_

• Chiesi Pharmaceuticals S.p.A._x000D_

What Trends Are Poised to Drive the Future Success of the Opioid Use Disorder (OUD) Market?

Product innovation is also gaining popularity in the opioid use disorder (OUD) market. Companies in this market are working on new products to strengthen their position. For example, in May 2023, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for the treatment of moderate to severe OUD. Brixadi is available in two forms: a weekly injection for patients who began treatment with transmucosal buprenorphine or are currently on the medication, and a monthly version for those already receiving it.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

What Are the Main Segments of the Opioid Use Disorder (OUD) Market, and How Are They Evolving?

The opioid use disorder (OUD) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

What Are the Leading Regions in the Opioid Use Disorder (OUD) Market Expansion?

North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Core Features That Define the Opioid Use Disorder (OUD) Market?

Opioid use disorder (OUD) is a chronic brain disease resulting from prolonged use of opioids, including both prescription painkillers and illegal opioids. Opioid use disorder can develop due to genetic, environmental, and behavioral factors.

Browse Through More Similar Reports By The Business Research Company:

Oral Thin Films Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report

Used Cars Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/used-cars-global-market-report

Used Truck Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/used-truck-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: